Chengbin Wang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Geriatrics and Gerontology top 5%
Papers in ⓘ
-
- Antibiotic Resistance in Bacteria 6
-
- Bacterial Identification and Susceptibility Testing 8
- Co-authors
- Ruibin Li (2 shared papers)Dandan Li (1 shared paper)Hang Zhu (1 shared paper)Hao Zhou (1 shared paper)Ting Xin (1 shared paper)Craig M. Wilson (2 shared papers)Richard A. Kaslow (2 shared papers)Jianming Tang (2 shared papers)
- Journals
- Journal of Clinical Laboratory Analysis (7 papers)Scientific Reports (3 papers)International Immunopharmacology (3 papers)Cytokine (3 papers)Medicine (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Chengbin Wang
109 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 290
- Geriatrics and Gerontology 62
- Epidemiology 501
- Hepatology 102
- Molecular Biology 855
Countries citing papers authored by Chengbin Wang
This map shows the geographic impact of Chengbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengbin Wang more than expected).
Fields of papers citing papers by Chengbin Wang
This network shows the impact of papers produced by Chengbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengbin Wang. The network helps show where Chengbin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy Hit paper breakdown → | 2018 | 277 |
| 2 | 2004 | 154 | |
| 3 | 2016 | 154 | |
| 4 | 2022 | 99 | |
| 5 | 2021 | 55 | |
| 6 | 2017 | 51 | |
| 7 | 2021 | 50 | |
| 8 | 2017 | 49 | |
| 9 | 2014 | 47 | |
| 10 | 2021 | 37 | |
| 11 | 2020 | 36 | |
| 12 | 2023 | 35 | |
| 13 | 2016 | 35 | |
| 14 | 2017 | 34 | |
| 15 | 2018 | 33 | |
| 16 | 2019 | 32 | |
| 17 | 2015 | 30 | |
| 18 | 2015 | 30 | |
| 19 | 2016 | 29 | |
| 20 | 2023 | 27 |
About Chengbin Wang
Chengbin Wang is a scholar working on Molecular Medicine, Clinical Biochemistry, Hematology, Epidemiology and Cancer Research, having authored 118 papers that have together received 2.0k indexed citations. Recurring topics across this work include Biosensors and Analytical Detection (8 papers), Bacterial Identification and Susceptibility Testing (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Hematological disorders and diagnostics (6 papers), Electrocatalysts for Energy Conversion (6 papers), MicroRNA in disease regulation (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Advanced battery technologies research (5 papers). The work is most often cited by research in Cancer Research (290 citations), Geriatrics and Gerontology (62 citations), Epidemiology (501 citations), Hepatology (102 citations) and Molecular Biology (855 citations). Chengbin Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Ruibin Li, Dandan Li, Hang Zhu, Hao Zhou, Ting Xin, Craig M. Wilson, Richard A. Kaslow, Jianming Tang, Wei Song and Elena Lobashevsky. Their work appears in journals such as Journal of Clinical Laboratory Analysis, Scientific Reports, International Immunopharmacology, Cytokine and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.